UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liraglutide for weight management: a critical review of the evidence

Obesity science & practice, 2017-03, Vol.3 (1), p.3-14

2017

Volltextzugriff (PDF)

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Cardiovascular diabetology, 2016-02, Vol.15 (1), p.29, Article 29

2016

Volltextzugriff (PDF)

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials

Diabetes, obesity & metabolism, 2018-03, Vol.20 (3), p.734-739

2018

Volltextzugriff (PDF)

Abciximab reduces mortality in diabetics following percutaneous coronary intervention

Journal of the American College of Cardiology, 2000-03, Vol.35 (4), p.922-928

2000

Volltextzugriff (PDF)

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Circulation (New York, N.Y.), 1999-12, Vol.100 (25), p.2477-2484

1999

Volltextzugriff (PDF)

Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience

Journal of the American College of Cardiology, 2001-08, Vol.38 (2), p.409-414

2001

Volltextzugriff (PDF)

Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque

European heart journal, 2007-06, Vol.28 (11), p.1283-1288

2007

Volltextzugriff (PDF)

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Diabetes, obesity & metabolism, 2015-05, Vol.17 (5), p.477-486

2015

Volltextzugriff (PDF)

Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry

European heart journal, 2010-01, Vol.31 (2), p.196-202

2010

Volltextzugriff (PDF)

The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics

Journal of the American College of Cardiology, 1999-04, Vol.33 (5), p.1269-1277

1999

Volltextzugriff (PDF)

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

Circulation (New York, N.Y.), 2003-05, Vol.107 (17), p.2238-2243

2003

Volltextzugriff (PDF)

Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis

The American journal of cardiology, 1998-08, Vol.82 (3), p.378-380

1998

Volltextzugriff (PDF)

Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting

The American heart journal, 2000-06, Vol.139 (6), p.939-944

2000

Volltextzugriff (PDF)

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

Circulation (New York, N.Y.), 2001-08, Vol.104 (7), p.815-819

2001

Volltextzugriff (PDF)

Liraglutide and Renal Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-08, Vol.377 (9), p.839-848

2017

Volltextzugriff (PDF)

Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience)

The American journal of cardiology, 1999-06, Vol.83 (11), p.1513-1517

1999

Volltextzugriff (PDF)

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2016-07, Vol.375 (4), p.311-322

2016

Volltextzugriff (PDF)

The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization

European heart journal, 1998-11, Vol.19 (11), p.1601-1603

1998

Volltextzugriff (PDF)

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

The New England journal of medicine, 2023-12, Vol.389 (24), p.2221-2232

2023

Volltextzugriff (PDF)

Peripheral Arterial Disease in Patients With Diabetes

Journal of the American College of Cardiology, 2006-03, Vol.47 (5), p.921-929

2006

Volltextzugriff (PDF)

Increase in interleukin-6 following arterial injury is related to insulin resistance, the −174G→C polymorphism and complex plaque morphology

International journal of immunogenetics, 2006-10, Vol.33 (5), p.347-354

2006

Volltextzugriff (PDF)

Diabetes mellitus: biological determinants of atherosclerosis and restenosis

Seminars in interventional cardiology : SIIC, 1999-09, Vol.4 (3), p.129

1999

Volltextzugriff (PDF)

Intracoronary stenting: an overview for the clinician

Cleveland Clinic journal of medicine, 1999-07, Vol.66 (7), p.434-442

1999

Volltextzugriff (PDF)

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

Journal of the American College of Cardiology, 2005-09, Vol.46 (5), p.821-826

2005

Volltextzugriff (PDF)

LEADER Study: Testing the Cardiovascular Safety of Liraglutide

MD conference express, 2013-11, Vol.13 (17), p.14-15

2013

Volltextzugriff (PDF)

1 – 25 von 460

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(392)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(265)
Life Sciences & Biomedicine
(161)
Humans
(155)
Female
(120)
Male
(120)
Cardiovascular System & Cardiology
(119)
Cardiac & Cardiovascular Systems
(113)
Middle Aged
(105)
Aged
(104)
Physical Sciences
(82)
Technology
(79)
Physics
(69)
Engineering
(65)
Engineering, Electrical & Electronic
(64)
Cardiovascular
(63)
Risk Factors
(63)
Biological And Medical Sciences
(58)
Medical Sciences
(57)
Treatment Outcome
(55)
Physics, Applied
(49)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Liraglutide for weight management: a critical review of the evidence

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials

Abciximab reduces mortality in diabetics following percutaneous coronary intervention

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience

Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry

The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis

Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

Liraglutide and Renal Outcomes in Type 2 Diabetes

Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience)

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Peripheral Arterial Disease in Patients With Diabetes

Increase in interleukin-6 following arterial injury is related to insulin resistance, the −174G→C polymorphism and complex plaque morphology

Diabetes mellitus: biological determinants of atherosclerosis and restenosis

Intracoronary stenting: an overview for the clinician

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

LEADER Study: Testing the Cardiovascular Safety of Liraglutide

Suchergebnisse filtern